Document Detail


Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.
MedLine Citation:
PMID:  12970025     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Restrictive cardiomyopathy frequently complicates primary systemic amyloidosis (AL), yet only a small number of these patients develop large pleural effusions refractory to diuretic therapy and thoracentesis. We hypothesized that disruption of pleural function by amyloid deposits underlies persistent pleural effusions (PPEs) in patients with AL disease. METHODS: We performed a retrospective study of AL patients with and without PPEs who had been referred to Boston University between 1994 and 2001. The presence of PPEs was defined by a failure to resolve the condition with thoracentesis and aggressive diuresis. AL cardiomyopathy patients without pleural effusions constituted the control (cardiac) group. Indexes of plasma cell dyscrasia, nephrotic syndrome, thyroid function, and echocardiographic measures of left and right ventricle performance were compared between groups. When available, closed needle biopsies and autopsy specimens of parietal pleura were examined for amyloid deposits. RESULTS: Among 636 patients with AL, 35 PPE patients underwent a median of three thoracenteses each. No statistical differences were found between the PPE and cardiac groups in echocardiographic measures of septal thickness, left ventricular systolic function, or diastolic compliance. Right ventricular (RV) hypokinesis occurred more often in PPE patients; however, nearly half of this group had normal RV systolic function. Renal function, plasma protein levels, and thyroid function were the same between groups. Nephrotic range proteinuria (ie, > 3 g/d) was more prevalent in the cardiac group than in the PPE group (44% vs 26%, respectively; p = 0.057). All pleural biopsies in the PPE group (six biopsies) revealed amyloid deposits. Autopsy samples of parietal pleura were negative for disease in two cardiac patients. Eighteen patients had chest tubes placed, and 11 underwent pleurodesis. PPE signaled limited survival among patients who were ineligible for treatment. Untreated PPE patients lived a median 1.8 months vs 6 months for untreated cardiac patients (p = 0.031). Survival after intensive chemotherapy and autologous stem cell transplantation was comparable in the PPE and cardiac groups (21.8 vs 15.6 months, respectively; p = 0.405). CONCLUSION: In AL patients with cardiac amyloid, neither echocardiographic measures of ventricular function nor the degree of nephrosis distinguished those patients with PPEs. We conclude that pleural amyloid infiltration plays a central role in the creation and persistence of pleural effusions among patients with AL.
Authors:
John L Berk; Joseph Keane; David C Seldin; Vaishali Sanchorawala; Jun Koyama; Laura M Dember; Rodney H Falk
Related Documents :
9432375 - Hla-dr2 phenotype and plasma lysozyme, beta-glucuronidase and acid phosphatase levels i...
18507195 - Could ifn-gamma predict the development of residual pleural thickening in tuberculous p...
3191455 - Diagnostic value of ferritin in malignant pleural and peritoneal effusions.
8356985 - Etiology of large pericardial effusions.
829365 - Measurement of cerebrospinal fluid igg in the diagnosis of multiple sclerosis.
20207865 - Automated detection of malaria-associated pseudoeosinophilia and abnormal wbc scattergr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Chest     Volume:  124     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-09-12     Completed Date:  2003-10-15     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  969-77     Citation Subset:  AIM; IM    
Affiliation:
Amyloid Treatment and Research Program, Department of Medicine, Boston University School of Medicine, Boston, MA, USA. jberk@lung.bumc.bu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Amyloidosis / complications*,  diagnosis,  pathology
Biopsy, Needle
Cardiomyopathy, Restrictive / complications*,  diagnosis,  pathology
Diagnosis, Differential
Echocardiography
Female
Humans
Male
Middle Aged
Myocardium / pathology
Pleura / pathology
Pleural Effusion / diagnosis,  etiology*,  pathology
Recurrence
Survival Rate
Grant Support
ID/Acronym/Agency:
FD-R 001346/FD/FDA HHS; HL 68705/HL/NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during di...
Next Document:  Etiology and pleural fluid characteristics of large and massive effusions.